ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by Mutual Advisors LLC

Mutual Advisors LLC lowered its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 5.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 38,376 shares of the company’s stock after selling 2,084 shares during the quarter. Mutual Advisors LLC’s holdings in ARK Genomic Revolution ETF were worth $931,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Wealthcare Advisory Partners LLC increased its holdings in shares of ARK Genomic Revolution ETF by 2.8% in the fourth quarter. Wealthcare Advisory Partners LLC now owns 15,903 shares of the company’s stock valued at $374,000 after purchasing an additional 435 shares during the period. Crescent Grove Advisors LLC grew its position in ARK Genomic Revolution ETF by 1.6% in the 3rd quarter. Crescent Grove Advisors LLC now owns 28,914 shares of the company’s stock valued at $740,000 after buying an additional 460 shares during the last quarter. National Bank of Canada FI increased its stake in ARK Genomic Revolution ETF by 28.4% in the 3rd quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock valued at $106,000 after buying an additional 920 shares during the period. Brown Miller Wealth Management LLC raised its position in ARK Genomic Revolution ETF by 5.5% during the 3rd quarter. Brown Miller Wealth Management LLC now owns 17,974 shares of the company’s stock worth $460,000 after buying an additional 933 shares during the last quarter. Finally, Dynamic Advisor Solutions LLC lifted its stake in shares of ARK Genomic Revolution ETF by 7.8% in the 3rd quarter. Dynamic Advisor Solutions LLC now owns 13,590 shares of the company’s stock worth $348,000 after acquiring an additional 989 shares during the period.

ARK Genomic Revolution ETF Trading Up 14.7 %

Shares of ARK Genomic Revolution ETF stock opened at $27.09 on Friday. The business’s 50-day moving average price is $24.89 and its 200-day moving average price is $25.14.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.